In summary, we reported a case of PHO with synovium hyperplasia which was refractory to treatment and highlighted the importance of aberrant CD200/CD200R1 in the regulation of the endothelial activation that contribute to the development of synovium hyperplasia. This evidence concerns the gene CD200 and primary hypertrophic osteoarthropathy.